IMPACT OF REPEAT TRANSURETHRAL RESECTION ON TREATMENT RESULTS IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER
- Authors: Khalmurzayev O.A.1, Matveev V.B.1, Figurin R.M.1, Romanov V.A.1, Panakhov A.D.1, Khafizov K.O.1
-
Affiliations:
- Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
- Issue: Vol 8, No 4 (2012)
- Pages: 33-39
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER
- Published: 30.12.2012
- URL: https://oncourology.abvpress.ru/oncur/article/view/353
- DOI: https://doi.org/10.17650/1726-9776-2012-8-4-33-39
- ID: 353
Cite item
Full Text
Abstract
The results of treatment were analyzed in 308 in patients with non-muscle-invasive (NMI) bladder cancer (BC). The incidence of recurrences was studied in patients with NMI BC who had undergone primary and second look (SL) transurethral resection (TUR). SL TUR is used to identify residual Т1G2−G3 tumors and to specify the stage of the disease, owing to which treatment policy for BC is changed. The authors revealed significant differences between the groups in the rate of early and recurrent NMI BC and its occurrence time during 5 years. The findings show the benefit of relapse-free survival after SL TUR in the T1G2-G3 BC group (p = 0.018). The authors also discuss whether it is reasonable to use SL TUR that allows this procedure to be recommended for patients with G2-G3 NMI BC in routine clinical practice.
About the authors
O. A. Khalmurzayev
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: oybekkhalmurzaev@mail.ru
Russian Federation
V. B. Matveev
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: oybekkhalmurzaev@mail.ru
Russian Federation
R. M. Figurin
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: oybekkhalmurzaev@mail.ru
Russian Federation
V. A. Romanov
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: oybekkhalmurzaev@mail.ru
Russian Federation
A. D. Panakhov
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: oybekkhalmurzaev@mail.ru
Russian Federation
K. O. Khafizov
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: oybekkhalmurzaev@mail.ru
Russian Federation
References
Supplementary files

